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Abstract
Background: The nutritional care provided to moderately premature babies is poorly studied. For a large cohort of
such babies, we aimed to describe: nutrition practice intentions, comparison of the intended with the actual
practice, compliance of actual practice to current nutrition guidelines, and postnatal growth.
Methods: A questionnaire was sent out to 29 neonatal intensive care units in France, in order to address practice
intentions. In the same units, retrospective patient’s data were collected to assess actual practice, compliance to
nutrition guidelines and infant postnatal growth. The cumulative nutritional deficit during the two first weeks of life
was calculated and variables associated with ΔZ-score for weight at 36 weeks postconceptional age/discharge
(ΔZ-scorew 36PCA/DC) were analysed by multivariate linear regression.
Results: 276 infants born 30 to 33 weeks of gestation were studied. Among them, 76 % received parenteral
nutrition on central venous line after birth. On day of life 1 (DOL1), 93 % of infants had parenteral amino acids
(AA), at an intake ≥ 1.5 g/kg in 27 % of cases. Lipids were started at ≤ DOL2 in 47 % of infants. There was a
divergence between the intended and the actual practice for both AA and lipids intake. The AA and energy
cumulative deficit (DOL1 to DOL14) were respectively 10.9 ± 8.3 g/kg and 483 ± 181 kcal/kg. Weight Z-score
(mean ± SD) significantly decreased from birth (−0.17 ± 0.88) to 36 weeks PCA/DC (−1.00 ± 0.82) (p < 0.0001), and
the extra-uterine growth retardation (EUGR) rate at 36 weeks PCA/DC was 24.2 %. Independent variables associated
with ΔZ-scorew 36PCA/DC were AA cumulative intake and DOL of full enteral feeding.
Conclusions: Nutrition intake was not in compliance with recommendations, and the rate of EUGR was
considerable in this cohort. Efforts are needed to improve adherence to nutrition guidelines and growth outcome
of moderately preterm infants.
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Background
In the last decades, several studies demonstrated serious
cumulative nutritional deficit and extra-uterine growth
retardation (EUGR) in preterm infants during the first
weeks of life [1–3].
More recently, the causes of this growth failure have
been explored and in part identified. The implementation
of continuous education, the carrying out of surveys to
focus on trends in clinical practice [4, 5] and the adher-
ence of postnatal nutrition to current recommendations,
have been addressed as possible solutions for improving
growth and reducing EUGR [6, 7].
All this literature relates to extremely or very low birth
weight (VLBW) infants and very little is known about
the nutritional care of the more “healthy” but still imma-
ture babies, born between 30 and 33 weeks of gestational
age (GA), even though they account for 15 % of preterm
life births and 30 % of neonatal intensive care unit
(NICU) admissions.
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Some reports have demonstrated that these infants,
too, fail to achieve intrauterine growth rates during hos-
pital stay and that significant variations in feeding prac-
tices and growth outcomes exist among NICUs [8, 9].
However, to date, no study has evaluated the adherence
to guidelines for energy and amino acids (AA) intake in
this specific population.
Infants within this cohort are generally less “sick”
when compared with their very preterm counterparts
and they have more subtle feeding issues and complica-
tions. Moreover, they often require a limited techno-
logical support and the choice of avoiding the central
venous line (CVL) insertion – in order to reduce the
possible associated complications - may limit the supply
of the recommended protein and caloric intake, espe-
cially during the transitional period [10].
So, the determinants of postnatal growth and the fac-
tors influencing the adequacy of nutrition support in
moderately preterm babies may be different from those
of VLBW infants and deserve a better understanding.
The aims of this study were the following: 1) to de-
scribe nutrition practice intentions in a large cohort of
moderately premature babies; 2) to compare nutrition
practice intentions to actual practice; 3) to describe the
adherence of units’ actual practice to current nutrition
guidelines; 4) to measure the growth outcomes during
hospital stay in this cohort.
Methods
Setting and participants
A survey was carried out in 2014 in French mainland and
overseas departments and territories. It was designed to in-
clude a heterogeneous group of preterm infants born be-
tween 30 and 33 weeks of gestation and cared for in
tertiary NICUs or secondary (IIB) level nurseries. For the
purpose of this study, infants born between 30 to 33 weeks
of gestation were defined “moderately premature babies".
The survey consisted of one-page questionnaire and an
electronic file to collect patients’ data. The aims of the
questionnaire and of the electronic file were respectively to
address the unit nutrition practice intentions and to de-
scribe the actual adherence to current nutrition guidelines.
The questionnaire was addressed to the senior phys-
ician of each unit or to a delegated colleague having clin-
ical experience of neonatal intensive care, and it
consisted of multiple choice and open-ended questions.
Specifically for infants born at 30–31 and at 32–33
weeks of gestation, the questionnaire assessed the fol-
lowing variables: whether written nutrition guidelines
were available in the unit, whether parenteral nutrition
(PN) was considered since the day of birth, the type of
venous access chosen in case of PN, postnatal day on
which parenteral AA and lipid intake was started, AA
starting dose, postnatal day on which enteral feeding
was started, enteral feeding advancement and fortifica-
tion strategy.
PN was defined as “intravenous nutrition given through
a central or peripheral line and containing at least both
dextrose and nitrogen”, full enteral feeding as “enteral feed
given as sole nutritional source”. Day of life (DOL) 1 was
defined as the day of birth.
In each centre, respondents were asked to record data
from the last consecutive 12 patients on the electronic
file (3 patients for each GA, born from 30 to 33 weeks
of gestation) being at 36 weeks postconceptional age
(PCA) or discharged from the unit.
Exclusion criteria were: major or digestive congenital
anomalies, outborn, transfer to other hospital within
DOL14 and death within the first week of life.
Data collection and management
The identity of the respondent to the questionnaire and
that of the centre’s electronic file were both blinded for the
analysis to all authors. Patients’ records were anonymous.
Data recording for this study was approved by the
National Committee for data protection (Commission
Nationale de l’Informatique et des Libertés, registra-
tion number 1687438).
This study was approved by the institutional medical
research ethics committee (Comité de Protection des
Personnes Sud-Ouest et Outre Mer III, authorization
number 2013/76). According to French legislation, writ-
ten parental consent was not needed for this study.
Demographic features and in-hospital morbidities were
collected. The following data were recorded on DOL1, 3,
7, 14 and at 36 weeks PCA or at discharge (DC) (when
before 36 weeks PCA): weight, parenteral (g/Kg/d of
dextrose, AA and lipids) and enteral intake (ml/kg/d of
human or given formula milk), whether a central or per-
ipheral venous line was inserted.
Mean human milk content was assumed to be 64 kcal⁄dl,
1.4 g/dl of protein, 3.2 g/dl of fat and 7.0 g⁄dl of carbohy-
drate. Human milk fortifier and preterm infant formula
compositions were based on the product’s labelled nutri-
tional content.
Head circumference and length were measured at birth
and at 36 weeks PCA/DC. Finally, information was re-
trieved on total days of PN on central and peripheral ven-
ous line, DOL on which trophic or enteral feeding was
started, DOL on which milk fortification was started, type
and amount of milk fortifier, DOL of full enteral feeding
and maximal postnatal weight loss.
Variables of interest and statistical analysis
Nutrition practice intentions
Nutrition practice intentions were compared to the ac-
tual practice with regard to the following variables: type
of venous access at birth, DOL of initiation of enteral
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feeding, DOL of initiation for parenteral AA and lipids
and AA starting dose.
Adherence of unit actual practice to current nutrition
guidelines
Compliance to nutrition guidelines was measured accord-
ing to current European recommendations [11] with the
theoretical values recently indicated per GA group [12].
Nutrition intake was considered compliant to guidelines if:
i) AA initiation dose (≥1.5 g/kg/d) was started at DOL1; ii)
AA target dose (≥3.5 g/k/d) was attained by DOL7; iii) en-
ergy target dose (≥120 kcal/kg/d) was attained by DOL7.
The cumulative AA (g/kg) and energy intake (Kcal/kg)
(DOL1 to DOL14) was estimated according to the
formula:
Cumulative intake ¼ DOL1intake  1:5ð Þ
þ DOL3intake  3ð Þ
þ DOL7intake  5:5ð Þ
þ DOL14intake  4ð Þ
Formula elaboration and validation
The formula was elaborated based on the assumption
that a linear progression of intake occurred between
DOL1 to DOL3, DOL3 to DOL7, and DOL7 to DOL14,
and it was validated in a subgroup of the cohort study:
in 48 infants (from 4 units) the AA and energy intake
was collected daily from DOL1 to DOL14 and the actual
cumulative intake (DOL1 to DOL14) was correlated to
the cumulative intake estimated by the formula by a lin-
ear regression procedure. The model showed a very
good regression coefficient (r2 = 0.9729; p < 0.001 and
0.9648; p < 0.001 respectively for AA and energy intake).
In all infants, the cumulative deficit (DOL1 to DOL14)
for AA and energy was calculated as following:
Cumulative deficit ¼ Target dose  14ð Þ − Cumulative intake
For the purpose of some analyses, infants and centres
were split into tertiles of respectively AA cumulative in-
take and mean AA cumulative intake.
Growth outcomes
Z-score [mean and standard deviation (SD) for GA] for
weight, length and head circumference was calculated at
birth and at 36 weeks PCA/DC, according to the refer-
ence [13].
Infants were considered SGA when the sex- and age-
adjusted weight at birth was below the 10th percentile
according to the reference [13].
They were defined EUGR when they were not born
SGA and the sex- and age-adjusted weight at birth and
at 36 weeks PCA/DC was below the 10th percentile ac-
cording to the reference [13].
Simple and multiple linear regressions were performed
to investigate variables associated with the delta Z-score
for weight at 36 weeks PCA/DC (ΔZ-scorew 36PCA/DC).
Potential cofounders were selected among antenatal (ste-
roids administration, preeclampsia, diabetes, labour, mode
of delivery), clinical (GA, gender, singleton birth, SGA,
surfactant administration, phototherapy, hypoglycemia,
Apgar ≤ 3 at 1 min, neonatal morbidities) and nutritional
(CVL insertion at birth, DOL of enteral feeding initiation,
DOL of full enteral feeding, tertile of AA cumulative in-
take, center tertile for mean AA cumulative intake, cu-
mulative energy intake) factors. These were included in
the multivariate model only if they were significant at a
p value < 0.10. The coefficient of determination (r2) of
the model was calculated, in order to choose the best-
fit equation for the data set.
Comparisons between groups were performed using
χ2-test (or Fisher’s exact test) for categorical variables;
the ANOVA test was used for parametric variables and
the Mann–Whitney U test for non-parametric continu-
ous variables.
All statistical analyses were carried out using the Med-
Calc. ver. 12.3.0.0 statistical software package (MedCalc
Software Mariakerke, Belgium) and p values <0.05 were
considered statistically significant.
Results
Questionnaire responses and study population
A total of 29 units were surveyed. Four units were sec-
ondary excluded as they only provided responses to the
questionnaire without feedback of patients’ data.
So, finally, 25 units were included in the analysis (23
III level NICUs and 2 IIB level nurseries).
Data of 276 patients were analysed. Population charac-
teristics are presented in Table 1.
Table 2 shows the questionnaires responses (intended
practice) according to groups of GA.
Nutritional actual practice
Among the 276 infants, 92 % had a PN and 76 % a CVL
for PN. The mean duration of PN on CVL was 9.0 ±
8.1 days.
The average time of initiation of enteral feeding was
1.7 ± 1.2 DOL. Feeding volume (mean ± SD) was ad-
vanced from 9 ± 12 ml/kg/d on DOL1 to 38 ± 26 ml/kg/d
on DOL3, reaching 87 ± 48 ml/kg/d at DOL7 and 140 ±
50 ml/kg/d by DOL14. The average day of full enteral
feeding was 11.7 ± 6.9 DOL. A total of 73 % of all study
subjects received human milk during their hospital stay
and 42 % were at least partially breastfed at 36 weeks
PCA/DC. The average time of initiation of milk fortifier
was 9.9 ± 5.5 DOL. The global rate of milk fortification
was 65 % and 36 % of all infants received fortified feeding
at 36 weeks PCA/DC.
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Parenteral AA were started on DOL1 in 93 % of infants,
the administered dose at DOL1 was ≥ 1.5 g/kg in 27 % and
lipid administration was started at ≤DOL2 in 47 %. The
results on the AA and lipid administration practice and
the comparison of the intended and actual practice ac-
cording to groups of GA are presented in Table 3.
For the all population study, the AA intake (g/kg/d) was
1.1 ± 0.7 at DOL1; 2.9 ± 0.9 at DOL7, and the energy intake
(kcal/kg/d) 94 ± 18 at DOL7. The cumulative AA (g/kg)
and energy intake (kcal/kg) were respectively 37.0 ± 8.3
and 1201 ± 166 and the correspondent cumulative deficits
were 10.9 ± 8.3 and 483 ± 181.
Growth outcomes
Table 4 details study population Z-scores and ΔZ-scores
for anthropometric measures at birth and at 36 weeks
PCA/DC.
For the all population study, the maximal postnatal
weight loss was 8.3 ± 3.9 %. At 36 weeks PCA/DC the
rate of babies whose weight was below the 10th percent-
ile according to the reference13 was 36.7 % (12.5 % of in-
fants being born SGA and 24.2 % having EUGR).
Variables associated with ΔZ-scorew 36PCA/DC at the
univariate analysis were: infant tertile for AA cumulative
intake, centre tertile for mean AA cumulative intake, cu-
mulative caloric intake, DOL of full enteral feeding,
SGA, GA, labour, Apgar ≤ 3 at 1 min of life, photother-
apy (data not shown). Variables associated with ΔZ-
score at 36 weeks PCA/DC at the multivariate analysis
are detailed in Table 5.
Variables associated with cumulative deficit of protein
intake (DOL 1–14) at the multivariate analysis are de-
tailed in Table 6.
Discussion
This study shows the poor postnatal growth of a moder-
ately premature population, demonstrating that both
EUGR rate and cumulative nutritional deficit are consid-
erable during the first weeks of life in infants born 30 to
33 weeks of gestation. The main result is that a better
nutritional intake may significantly reduce the ΔZ-
scorew from birth to 36 weeks PCA/DC in this vulner-
able population.
Critical illness, insufficient early PN support, lack of
education and training in PN prescription have been
proven responsible for the growth retardation acquired
during hospitalization of extremely and VLBW infants
[1, 14–16].
To our knowledge, this is the first time that the impact
of all these factors on the growth outcome has been ex-
plored for the specific population of more healthy but still
immature preterm babies. Indeed, several clinical and nu-
tritional variables potentially influencing the degree of
growth failure have been investigated by this report.
Studies in extremely low birth weight infants have
underlined that insufficient early PN support and EUGR
are a serious problem, especially for neonates who are
small, immature and critically ill, and that they are inde-
pendently associated to acute morbidities and illness
Table 1 Population characteristics (n = 276 preterm infants born
30–33 weeks gestation)
Antenatal variables
Preeclampsia, n (%) 68 (25.5)
Maternal Diabetes, n (%) 35 (12.8)
Antenatal Steroids, n (%) 251 (91.6)
Singleton Pregnancy, n (%) 62 (22.2)
Infant characteristics
Birth Weight (g), mean ± SD 1582 ± 375
Length (cm), mean ± SD 39.9 ± 3.1
Head Circumference (cm), mean ± SD 28.4 ± 3.9
Gestational Age, n (30/31/32/33) 64/68/76/68
Small for gestational age, n (%) 33 (12)
Male Gender, n (%) 135 (48.9)
Caesarean Section, n (%) 175 (63.6)
Apgar score≤ 3 at 5 min, n (%) 6 (4.0)
Hypoglycemia requiring treatment, n (%) 36 (13.3)
Phototherapy, n (%) 219 (79.6)
Surfactant Administration, n (%) 85 (30.8)
Mechanical Ventilation, n (%) 91 (33.3)
Early Onset Sepsis, n (%) 12 (4.4)
Late Onset Sepsis, n (%) 29 (10.5)
Necrotizing enterocolitis, n (%) 4 (1.4)
Intraventricular haemorrhage grade 1–2, n (%) 35 (12)
Intraventricular haemorrhage grade 3–4, n (%) 2 (0.7)
Cystic periventricular leukomalacia, n (%) 5 (1.8)
Hospital Stay (days), mean ± SD 32.5 ± 15.8
Table 2 Questionnaires responses (intended practice) according
to groups of GA (25 units)
30-31 weeks 32-33 weeks
Written unit guidelines, n (%) 18 (72) 19 (76)
PN started on DOL1, n (%) 22 (88) 14 (56)
CVL for PN, n (%) 11 (44) 4 (16)
AA parenteral initiation, DOL (mean ± SD) 1.08 ± 0.4 1.13 ± 0.6
AA parenteral initiation dose, g (mean ± SD) 1.39 ± 0.59 1.31 ± 0.58
Lipid parenteral initiation, DOL (mean ± SD) 2.0 ± 0.6 2.1 ± 0.4
Enteral Feeding Initiation, DOL (mean ± SD) 1.3 ± 0.5 1.2 ± 0.4
Enteral Feeding Advancement, ml/kg/d
(mean ± SD)
18.2 ± 5.0 19.6 ± 5.6
Mother milk fortification, n (%) 23 (92) 19 (76)
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conditions (i.e. need for assisted ventilation, necrotizing
enterocolitis) [1].
Recently, Santerre and Rigo [6, 7] have shown that
early postnatal nutrition is critical to limit the EUGR
and that nutritional policy and growth can be optimized
by the respect of current recommendations, even in ba-
bies with severe prematurity-related morbidities.
Their observation was assessed in a cohort of ex-
tremely and VLBW infants, but based on our results, it
may also apply to a more healthy population of larger
babies and more advanced GA.
Our study has also documented that shorter time to
achieve full enteral feeding was significantly associated
with a more favourable growth outcome. This is consist-
ent with the results of Ehrenkranz et al. [17], in a pro-
spective cohort of VLBW infants and those of Blackwell
et al. [8], in a large cohort of healthy, premature infants
born between 30 and 35 weeks of gestational age. In this
retrospective study, which did not take into account the
use of PN, earlier initiation of enteral feeding and higher
feeding volumes over the first week of life were corre-
lated with lower weight loss during that period.
Interesting also, in our study, cumulative protein def-
icit appears significantly lower in babies with lower ges-
tational ages and with intrauterine growth retardation, it
is inversely associated with centre tertile for mean AA
intake and with the use of CVL on DOL1, and it is not
influenced by prematurity-related morbidities.
According to all the above data, differences in growth
in our population would more clearly reflect differences
in nutritional care and may reveal more effective feeding
strategies among centres. This result has interesting im-
plications for clinicians and NICU policies.
In an original way, this study aimed to evaluate the ad-
herence of the intended and the actual practices to the
recommended PN guidelines for preterm infants, even if
the information was collected within the limits of the
starting administration of AA and lipids. It is worthwhile
to note that, whether both the practices for DOL of
starting AA were in compliance with the established PN
guidelines, this was not the case for the AA starting
dose, or for lipids administration. This is an important
point to be addressed in the course of continuous educa-
tion strategies, because, as noticed in a recent report
from Fischer and coll. [18], early parenteral lipid intake
is positively associated with weight gain in extremely
low birth weight infants and may improve early nutri-
tional support of preterm neonates.
Finally, our results somehow show a discrepancy be-
tween what physicians intend to prescribe and what they
do really provide to preterm babies, and this leads to the
following considerations: the first one regards the meth-
odological limitation of using surveys for the assessment
of nutritional protocols, as already highlighted by previ-
ous reports [4, 15, 19]; the second one concerns the
need of greater efforts to implement the existing known
guidelines at the local level in NICUs.
The present study has several limitations. The
major one is undoubtedly that our data may not be
considered as representative of the entire population
of the moderately premature babies targeted by the
survey, especially with regards to results of intention-
to-treat practices, as questionnaires were not distributed
on a national basis, contrary to most surveys [8, 15]. A
further point is that some information were not available
in our report, that is the rate of daily nutriment
Table 3 Comparison of the intended and actual practice according to groups of GA (276 infants)
30-31 weeks 32-33 weeks
Intended Practice Actual Practice Intended Practice Actual Practice
CVL for PN (%) 63 92 31 61
Enteral feeding initiation DOL (mean) 1.3 1.9 1.2 1.5
PN started on DOL1 (%) 88 90 56 73
AA parenteral initiation at DOL1 (%) 88 94 88 92
AA parenteral initiation dose≥ 1.5 g/kg/d (%) 41 33 35 22
Lipid parenteral initiation≤ DOL2 (%) 91 54 82 41
Table 4 Z-scores and ΔZ-scores in 276 preterm infants born 30–33 weeks of gestation
Birth Z-score Z-score 36 weeks PCA/DC ΔZ-scorea pb
Weight (mean ± SD) −0.17 ± 0.88 −1.00 ± 0.82 −0.80 ± 0.47 <0.0001
Length (mean ± SD) −0.21 ± 1.14 −1.12 ± 1.09 −0.90 ± 0.91 <0.0001
Head Circumference (mean ± SD) 0.04 ± 1.04 −0.41 ± 0.92 −0.41 ± 0.74 <0.0001
aΔZ-score from birth to 36 weeks PCA/DC. bZ-score 36 weeks PCA/DC versus Birth Z-score (ANOVA for repeated measures)
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progression, the unit contraindications to enteral and
parenteral feeding advancement, the presence of meta-
bolic abnormalities (acidosis, hyperglycemia, hypertriglyc-
eridemia) during the first days of life, the incidence of
sepsis associated to CVL and finally the type of solutions,
additive and supplements used in PN. The model of mul-
tiple linear regression used to identify factors associated
with ΔZ-scorew at 36 weeks PCA/DC has a quite poor
general coefficient, suggesting that other variables not
considered in the analysis may account for explaining the
growth outcome in the studied population. Finally, the
present investigation was not designed to explore enteral
feeding practices in detail in terms of fortification strat-
egies, feeding techniques and breastfeeding polices, which
might produce differences in growth outcome, as illus-
trated by other studies [20, 21].
Conclusions
The results of our report have interesting implications
for clinicians and NICU policymakers. As already dem-
onstrated for extremely and VLBW infants, our study al-
lows to conclude that the nutrition delivered to infants
born 30–33 weeks gestation is often not in compliance
with international guidelines, and that this is associated
with considerable rates of EUGR.
The reasons for suboptimal AA and total calories de-
livery in this specific population mainly reside on unit
nutrition practice and feeding strategies, this making
that the growth outcome may be improved.
Factors influencing EUGR in moderately premature
babies are not fully elucidated, and further studies are
needed to identify practices associated with better
growth in this quite healthy, but still vulnerable infant
population.
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